Abstract
At present there is no established therapy for treating patients with hereditary hemorrhagic telangiectasia (HHT) and symptomatic hepatic involvement. We present the results of a prospective study with 15 consecutive patients who were treated with staged hepatic artery embolization (HAE). Branches of the hepatic artery were selectively catheterized and embolized in stages using polyvinyl alcohol particles (PVA) and platinum microcoils or steel macrocoils. Prophylactic antibiotics, analgesics and anti-emetics were administered after every embolization. Clinical symptomatology and cardiac output were assessed before and after therapy as well as at the end of follow-up (median 28 months; range 10–136 months). Five patients had abdominal pain and four patients had symptoms of portal hypertension. The cardiac output was raised in all patients, with cardiac failure being present in 11 patients. After treatment, pain resolved in all five patients, and portal hypertension improved in two of the four patients. The mean cardiac output decreased significantly (P<0.001) from 12.57±3.27 l/min pre-treatment to 8.36±2.60 l/min at the end of follow-up. Symptoms arising from cardiac failure resolved or improved markedly in all but one patient. Cholangitis and/or cholecystitis occurred in three patients of whom two required a cholecystectomy. One patient with pre-existent hepatic cirrhosis died as a complication of the procedure. Staged HAE yields long-term relief of clinical symptoms in patients with HHT and hepatic involvement. Patients with pre-existing hepatic cirrhosis may be poor candidates for HAE.
Similar content being viewed by others
References
Martini GA (1978) The liver in hereditary haemorrhagic teleangiectasia: an inborn error of vascular structure with multiple manifestations: a reappraisal. Gut 19:531–537
Reilly PJ, Nostrant TT (1984) Clinical manifestations of hereditary haemorrhagic teleangiectasia. Am J Gastroenterol 79:363–367
Bernard G, Mion F, Henry L, Plauchu H, Paliard P (1993) Hepatic involvement in hereditary haemorrhagic teleangiectasia: clinical, radiological and hemodynamic studies of 11 cases. Gastroenterology 105:482–487
Guttmacher AE, Marchuk DA, White RI (1995) Hereditary hemorrhagic telangiectasia. N Engl J Med 333(14):918–924
Haitjema T, Westermann CJ, Overtoom TT et al (1996) Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease): new insights into pathogenesis, complications and treatment. Arch Intern Med 156:714–719
Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936
Geisthoff UW, Schneider G, Fischinger J, Plinkert PK (2002) Hereditäre hämorrhagische Teleangiektasie (Morbus Osler): Eine interdisziplinäre Herausforderung. HNO 50:114–128
Chavan A, Galanski M, Wagner S, Caselitz M, Schlitt HJ, Gratz KF, Manns M (1998) Hereditary hemorrhagic telangiectasia: effective protocol for embolization of hepatic vascular malformations—experience in five patients. Radiology 209:735–739
DeLorimier A, Simpson E, Baum R et al (1967) Hepatic artery ligation for hepatic hemangiomatosis. N Engl J Med 277:333–337
Radtke WE, Smith HC, Fulton RE, Adson MA (1978) Misdiagnosis of atrial septal defect in patients with hereditary telangiectasia (Osler-Rendu-Weber disease) and hepatic arteriovenous fistulas. Am Heart J 95:235–242
Zentler-Munro PL, Howard ER, Karani J, Williams R (1989) Variceal haemorrhage in hereditary hemorrhagic telangiectasia. Gut 30:1293–1297
Neumann U-P, Knoop M, Langrehr J-M et al (1998) Effective therapy for hepatic M. Osler with systemic hypercirculation by ligation of the hepatic artery and subsequent liver transplantation. Transpl Int 11:323–326
Zieren J, Buttemeyer R, Muller JM (1998) Adjustable “banding” of the hepatic artery in treatment of shunt-induced heart failure in Osler-Rendu-Weber disease. Chirurg 69:639–641
Graham WP, Eiseman B, Pryor R (1964) Hepatic artery aneurysm with portal vein fistula in a patient with familial hereditary telangiectasia. Ann Surg 159:362–367
Göthlin JH, Nordgard K, Jonsson K, Nyman U (1982) Hepatic telangiectasia in Osler’s disease treated with arterial embolisation. Report of 2 cases. Eur J Radiol 2:27–30
Brohee D, Franken P, Fievez M et al (1984) High-output right ventricular failure secondary to hepatic arteriovenous microfistulae. Selective arterial embolization treatment. Arch Intern Med 144:1282–1284
Allison D, Jordon J, Hennessey O (1985) Therapeutic embolization of the hepatic artery: a review of seventy-five procedures. Lancet 1:595–599
Roman CF, Do Cha S, Incarvito J, Cope C, Maranhao V (1987) Transcatheter embolization of hepatic arteriovenous fistula in Osler-Weber-Rendu disease—a case report. Angiology 38:484–488
Derauf BJ, Hunter DW, Sirr SA, Cardella JF, Castaneda-Zuniga W, Amplatz K (1987) Peripheral embolization of diffuse hepatic arteriovenous malformations in a patient with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 10:80–83
Nikolopoulos N, Xynos E, Vassilakis JS (1988) Familial occurrence of hyperdynamic circulation status due to intrahepatic fistulae in hereditary hemorrhagic telangiectasia. Hepatogastroenterology 35:167–168
Bourgeois N, Delcour C, Deviere J et al (1990) Osler–Weber–Rendu disease associated with hepatic involvement and high output heart failure. J Clin Gastroenterol 12:236–238
Whiting JH Jr, Morton KA, Datz FL, Patch GG, Miller FJ Jr (1992) Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: case report. J Nucl Med 33(2):260–262
Caselitz M, Wagner S, Chavan A, Gebel M, Bleck JS, Wu A, Schlitt HJ, Galanski M, Manns M (1998) Clinical outcome of transfemoral embolisation in patients with arteriovenous malformations of the liver in hereditary haemorrhagic telangiectasia (Weber-Rendu-Osler disease). Gut 42:123–126
Trotter JF, Suhocki PV, Lina JR, Martin LW, Parrish JL, Swantkowski T (1998) Hereditary hemorrhagic telangiectasia causing high output cardiac failure: treatment with transcatheter embolization. Am J Gastroenterol 93:1569–1571
Odorico JS, Hakim NM, Becker YT et al (1998) Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia. Liver Transpl Surg 4:483–490
Chavan A, Galanski M, Wagner S, Caselitz M, Schlitt HJ, Gratz KF, Manns M (1999) Hereditary hemorrhagic telangiectasia (reply—letters to the editor). Radiology 213:928–930
Stockx L, Raat H, Caerts B et al (1999) Transcatheter embolization of hepatic arteriovenous fistulas in Rendu-Osler-Weber disease: a case report and review of the literature. Eur Radiol 9(7):1434–1437
Hisamatsu K, Ueeda M, Ando M et al (1999) Peripheral arterial coil embolization for hepatic arteriovenous malformation in Osler–Weber–Rendu disease; useful for controlling high output heart failure, but harmful to the liver. Intern Med 38:962–968
Whiting JH Jr, Korzenik JR, Miller FJ Jr et al (2000) Fatal outcome after embolotherapy for hepatic arteriovenous malformations of the liver in two patients with hereditary hemorrhagic telangiectasia. J Vasc Interv Radiol 11:855–858
Pfitzmann R, Heise M, Langrehr JM, Jonas S, Steinmüller T, Podrabsky P, Ewert R, Settmacher U, Neuhaus R, Neuhaus P (2001) Liver transplantation for treatment of intrahepatic Osler’s disease: first experiences. Transplantation 72:237–241
Bauer T, Britton P, Lomas D, Wight DG, Friend PJ, Alexander GJ (1995) Liver transplantation for hepatic arteriovenous malformation in hereditary haemorrhagic telangiectasia. J Hepatol 22:586–590
Saxena R, Hytiroglou P, Atillasoy EO et al (1998) Coexistence of hereditary hemorrhagic telangiectasia and fibropolycystic liver disease. Am J Surg Pathol 22:368–372
McInroy B, Zajko AB, Pinna AD (1998) Biliary necrosis due to hepatic involvement with hereditary hemorrhagic telangiectasia. Am J Roentgenol 170:413–415
Boillot O, Bianco F, Viale J-P et al (1999) Liver transplantation resolves the hyperdynamic circulation in hereditary hemorrhagic telangiectasia with hepatic involvement. Gastroenterology 116:187–192
Le Corre F, Golkar B, Tessier C et al (2000) Liver transplantation for hepatic arteriovenous malformation with high-output cardiac failure in hereditary hemorrhagic telangiectasia; hemodynamic study. J Clin Anesth 12:339–342
Hillert C, Broering DC, Gundlach M et al (2001) Hepatic involvement in hereditary hemorrhagic telangiectasia: an unusual indication for liver transplantation. Liver Transpl 7:266–268
Caselitz M, Chavan A, Manns MP, Wagner S (2001) Die Hereditäre Hämorrhagische Teleangiectasie (Morbus Osler–Rendu–Weber) und ihre Manifestation an der Leber. Z Gastroenterol 39:533–542
Larson AM (2003) Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 36(2):149–158
Jackson JE (1999) Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: treatment with embolization (Letter to the editor). Radiology 213:927–928
Miller FJ, Whiting JH, Korzenik JR, White RI (1999) Caution with use of hepatic embolization in treatment of hereditary hemorrhagic telangiectasia (Letter to the editor). Radiology 213:928
Miller FJ, Mineau DE (1983) Transcatheter arterial embolization—major complications and their prevention. Cardiovasc Intervent Radiol 6:141–149
Jain A, Reyes J, Kashyap R et al (2000) Long-term survival after liver transplantation in 4,000 consecutive patients at a single center. Ann Surg 232(4):490–500
Hatzidakis AA, Gogas C, Papanikolaou N, Samonakis D, Kofteridis D, Gourtsoyiannis NC (2002) Hepatic involvement in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease). Eur Radiol 12:S51–S55
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chavan, A., Caselitz, M., Gratz, KF. et al. Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations. Eur Radiol 14, 2079–2085 (2004). https://doi.org/10.1007/s00330-004-2455-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-004-2455-5